Precursor Cell Lymphoblastic Leukemia-Lymphoma
"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Descriptor ID |
D054198
|
| MeSH Number(s) |
C04.557.337.428.600 C15.604.515.560.600 C20.683.515.528.600
|
| Concept/Terms |
Precursor Cell Lymphoblastic Leukemia-Lymphoma- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Acute Lymphoblastic
- Acute Lymphoblastic Leukemia
- Leukemia, Lymphoblastic
- Leukemia, Lymphoblastic, Acute
- Leukemia, Lymphocytic, Acute
- Lymphoblastic Leukemia
- Lymphoblastic Leukemia, Acute
- Lymphoblastic Lymphoma
- Lymphocytic Leukemia, Acute
- Acute Lymphocytic Leukemia
- Leukemia, Acute Lymphocytic
- Lymphoma, Lymphoblastic
- Acute Lymphoid Leukemia
- Leukemia, Acute Lymphoid
- Lymphoid Leukemia, Acute
- Leukemia, Lymphoid, Acute
Leukemia, Lymphocytic, Acute, L1- Leukemia, Lymphocytic, Acute, L1
- Lymphocytic Leukemia, L1
- L1 Lymphocytic Leukemia
- Leukemia, L1 Lymphocytic
- Lymphoblastic Leukemia, Acute, Childhood
- Lymphoblastic Leukemia, Acute, L1
- ALL, Childhood
- Childhood ALL
- Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphocytic, Acute, L2- Leukemia, Lymphocytic, Acute, L2
- Lymphocytic Leukemia, L2
- L2 Lymphocytic Leukemia
- Leukemia, L2 Lymphocytic
- Lymphoblastic Leukemia, Acute, Adult
- Lymphoblastic Leukemia, Acute, L2
- Leukemia, Lymphoblastic, Acute, L2
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
|
Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 7 | 2 | 9 |
| 1994 | 3 | 2 | 5 |
| 1995 | 8 | 1 | 9 |
| 1996 | 2 | 4 | 6 |
| 1997 | 2 | 2 | 4 |
| 1998 | 8 | 0 | 8 |
| 1999 | 7 | 1 | 8 |
| 2000 | 8 | 0 | 8 |
| 2001 | 5 | 0 | 5 |
| 2002 | 4 | 1 | 5 |
| 2003 | 7 | 2 | 9 |
| 2004 | 5 | 0 | 5 |
| 2005 | 9 | 0 | 9 |
| 2006 | 4 | 0 | 4 |
| 2007 | 9 | 0 | 9 |
| 2008 | 8 | 2 | 10 |
| 2009 | 8 | 1 | 9 |
| 2010 | 7 | 2 | 9 |
| 2011 | 6 | 1 | 7 |
| 2012 | 7 | 0 | 7 |
| 2013 | 5 | 0 | 5 |
| 2014 | 2 | 2 | 4 |
| 2015 | 5 | 0 | 5 |
| 2016 | 11 | 1 | 12 |
| 2017 | 7 | 0 | 7 |
| 2018 | 11 | 1 | 12 |
| 2019 | 13 | 0 | 13 |
| 2020 | 15 | 0 | 15 |
| 2021 | 14 | 0 | 14 |
| 2022 | 18 | 0 | 18 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Am J Hematol. 2023 04; 98(4):666-680.
-
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. Blood Adv. 2023 01 24; 7(2):196-204.
-
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica. 2022 Dec 01; 107(12):2783-2793.
-
Epigenetic regulator genes direct lineage switching in?MLL/AF4 leukemia. Blood. 2022 10 27; 140(17):1875-1890.
-
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. JCO Precis Oncol. 2022 10; 6:e2200353.
-
D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia. Blood Adv. 2022 09 13; 6(17):5146-5151.
-
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2022 11; 69(11):e29937.
-
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia. Blood Adv. 2022 07 26; 6(14):4085-4092.
-
How I Diagnose Acute Leukemia of Ambiguous Lineage. Am J Clin Pathol. 2022 07 01; 158(1):27-34.
-
Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents. J Assist Reprod Genet. 2022 Aug; 39(8):1733-1738.